MYO241220P7500
- 2.70
- 0.000.00%
Myomo Newsroom
H.C. Wainwright Maintains Myomo(MYO.US) With Buy Rating, Maintains Target Price $7.5
Nvidia To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Ascendiant Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $9
Myomo Price Target Raised to $9.00/Share From $8.50 by Ascendiant Capital
Myomo Is Maintained at Buy by Ascendiant Capital
Myomo Analyst Ratings
Maxim Group Maintains Myomo(MYO.US) With Buy Rating
Myomo Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Sales Guidance Above Estimates.
Express News | Myomo Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Sales Guidance Above Estimates
12 Health Care Stocks Moving In Thursday's Intraday Session
Myomo, Inc. Reports Record Third Quarter Growth
Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript Summary
Express News | Myomo Expects Q4 Sales Guidance of $9.50M-10.50M VS Est.9.8M
Myomo Raises FY24 Revenue View to $30M-$31M From $28M-$30M
Myomo GAAP EPS of -$0.03 Beats by $0.01, Revenue of $9.21M Beats by $1.1M
Earnings Flash (MYO) MYOMO Posts Q3 Revenue $9.2M
Myomo | 10-Q: Q3 2024 Earnings Report
Myomo | 8-K: Myomo Reports Record Third Quarter Financial and Operating Results
Express News | Myomo Reports Record Third Quarter Financial and Operating Results
Express News | Myomo Q3 Operating Income USD -1 Million